Health Select Committee reports on the impact of Brexit on medicines, medical devices and substances of human origins
On Wednesday 21 March the House of Commons Health and Social Care Committee published a report titled "Brexit: medicines, medical devices and substances of human origins". The report emphasis that it is in the best interests of both citizens and the sector for there to be "the closest possible regulatory alignment" between the UK and EU post-Brexit. It also urges the Government to publish details of its contingency plans for the sector should a hard Brexit take place, to allow companies and health organisations to put in place the necessary plans.
The EU (Withdrawal) Bill completed its passage through the House of Commons on 17 January, receiving its first reading in the House of Lords the next day. While a huge number of amendments to the Bill were tabled during its time in the Commons, only a few substantive amendments were actually passed. We have summarised the key amendments made during the House of Commons and their potential impact on the Brexit process should they make it through the House of Lords.